Sanofi Active Ingredient Solutions

For innovative pharmaceutical companies, from start-ups to big pharma companies, generics pure players and through its catalogue of high-quality active ingredients and its contract development and manufacturing organisation, the company delivers expertise and customised solutions that contribute to the success of your business.

As a global leader, Sanofi Active Ingredient Solutions has been supporting customers for decades with innovative, efficient and safe solutions, high-quality products and premium customer service.

Contract development and manufacturing services for medical drugs

Sanofi Active Ingredient Solutions offers pharmaceutical drug developers in more than 80 countries with API and technological solutions, supporting partners from process development to regulatory submission.

Its expertise covers multiple therapeutic areas for human and animal health, including corticosteroids, hormones, viral vectors, multi-step chemistry, opiates, prostaglandins and high-active products, as well as plasmids, oligosaccharides, peptides, oligosaccharides, biotechnologies and monoclonal antibodies (mAb).

Sanofi Active Ingredient Solutions partners with innovative companies ranging from start-ups to some of the biggest pharmaceutical players. Its catalogue of high-quality APIs and customised CDMO services delivers expertise and contributes to key therapeutic solutions that help millions of people.

The company has been supporting customers for decades with innovative, efficient and safe solutions, as well as high-quality products and customer service. It focuses on the continuous improvement of manufacturing processes to optimise output and meet client expectations.

Sanofi Active Ingredient Solutions’ synthesis API portfolio covers cardiovascular disease, metabolic disorders, analgesics and non-fluorinated glucocorticoids and derivatives (NSAID), as well as central nervous system (CNS) disorders and anaesthetics.

In the corticosteroids and hormones field, the company has more than 60 years of experience, and is a fully integrated corticoids manufacturer.

Clinical supply and commercial manufacturing for the biotech industry

Sanofi Active Ingredient Solutions has been providing biotech customers with services ranging from clinical supply to commercial manufacturing since 1985. Using its dedicated biotech platform, the company has gained a significant track record, working on an average of more than 70 batches per year.

The company has 25 years of experience in the field of oligosaccharides. Sanofi Active Ingredient Solutions’ analytical expertise guarantees purity and quality, while its robust supply chain is widely recognised.

Fermentation technologies, nutraceuticals, vitamins and probiotics

Sanofi Active Ingredient Solutions offers large-volume fermentation services and has proven expertise in nutraceuticals, vitamins and probiotics.

The company meets clients’ specific demands with the highest standards.

It has a long-standing expertise in organic chemistry with specific competencies in complex and long synthesis, as well as supports its customers’ projects from early phases through to validation campaigns.

APIs for human and animal health

Sanofi Active Ingredient Solutions is a world leader in the manufacturing of prostaglandins, with a strong historical background in process development and the scale-up of new chemical entities. Its portfolio includes 18 prostaglandin APIs.

The company’s production lines are multi-purpose, allowing quick and flexible developments and scale-ups, along with constant high quality. It also provides exhaustive regulatory support to its customers.

Sanofi Active Ingredient Solutions is the sole European vitamin B12 manufacturer, while its biotech API catalogue offers 14 APIs, including antibiotics and anti-tuberculosis.

Beyond the APIs, the company has developed a strong customer-oriented policy with a large range of possible specifications and customisations.

Opiates from poppy seeds to APIs

Sanofi Active Ingredient Solutions provides opiates in forms ranging from poppy seeds to APIs.

The company’s portfolio comprises 15 opiate APIs with applications in agronomic research, industrial and agricultural production, and distribution. It grows and harvests 10,000 ha of poppies each year.